Outcomes of in-hospital cardiac arrest in COVID-19 patients: A proportional prevalence meta-analysis

Catheter Cardiovasc Interv. 2022 Jan 1;99(1):1-8. doi: 10.1002/ccd.29525. Epub 2021 Feb 4.

Abstract

Background: Limited epidemiological data are available on the outcomes of in-hospital cardiac arrest (CA) in COVID-19 patients.

Methods: We performed literature search of PubMed, EMBASE, Cochrane, and Ovid to identify research articles that studied outcomes of in-hospital cardiac arrest in COVID-19 patients. The primary outcome was survival at discharge. Secondary outcomes included return of spontaneous circulation (ROSC) and types of cardiac arrest. Pooled percentages with a 95% confidence interval (CI) were calculated for the prevalence of outcomes.

Results: A total of 7,891 COVID patients were included in the study. There were 621 (pooled prevalence 8%, 95% CI 4-13%) cardiac arrest patients. There were 52 (pooled prevalence 3.0%; 95% CI 0.0-10.0%) patients that survived at the time of discharge. ROSC was achieved in 202 (pooled prevalence 39%;95% CI 21.0-59.0%) patients. Mean time to ROSC was 7.74 (95% CI 7.51-7.98) min. The commonest rhythm at the time of cardiac arrest was pulseless electrical activity (pooled prevalence 46%; 95% 13-80%), followed by asystole (pooled prevalence 40%; 95% CI 6-80%). Unstable ventricular arrhythmia occurred in a minority of patients (pooled prevalence 8%; 95% CI 4-13%).

Conclusion: This pooled analysis of studies showed that the survival post in-hospital cardiac arrest in COVID patients is dismal despite adequate ROSC obtained at the time of resuscitation. Nonshockable rhythm cardiac arrest is commoner suggesting a non-cardiac cause while cardiac related etiology is uncommon. Future studies are needed to improve the survival in these patients.

Keywords: COVID-19; in-hospital cardiac arrest; mortality; pulseless electrical activity.

Publication types

  • Meta-Analysis

MeSH terms

  • COVID-19*
  • Cardiopulmonary Resuscitation*
  • Heart Arrest* / diagnosis
  • Heart Arrest* / epidemiology
  • Hospitals
  • Humans
  • Prevalence
  • SARS-CoV-2
  • Treatment Outcome